Mutated variant of human vascular endothelial growth factor as a vaccine candidate for cancer immunotherapy

Mutated variant of human vascular endothelial growth factor as a vaccine candidate for cancer immunotherapy

Bibliographic Details
Main Authors:	Mónica Bequet-Romero, Yanelys Morera, Marta Ayala, Boris E Acevedo, Humberto Lamdan, Jorge V Gavilondo
Format:	Article
Language:	English
Published:	Elfos Scientiae
Series:	Biotecnología Aplicada
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522009000100009&lng=en&tlng=en

Similar Items

CIGB-247 vaccine breaks immunological tolerance to the vascular endothelial growth factor in mice, rats, rabbits and non-human primates, without disturbing physiologic angiogenic processes
by: Yanelys Morera, et al.

Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?
by: Javier Sánchez Ramírez, et al.
Published: (2019-06-01)

Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants
by: Javier Sánchez Ramírez, et al.
Published: (2017-07-01)

Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.
by: Kevin D Pavelko, et al.
Published: (2011-01-01)

Mutation burden of rare variants in schizophrenia candidate genes.
by: Simon L Girard, et al.
Published: (2015-01-01)

Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors
by: Javier Sánchez Ramírez, et al.
Published: (2018-11-01)

Characteristics of Candidates for Allergen Immunotherapy
by: Giorgio Ciprandi M.D., et al.
Published: (2013-09-01)

Genetic variants of vascular endothelial growth factor predict risk and survival of gliomas
by: Paulo Linhares, et al.
Published: (2018-03-01)

Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants.
by: Katie M O'Brien, et al.
Published: (2013-01-01)

Identification of Two Novel Candidate Genetic Variants Associated With the Responsiveness to Influenza Vaccination
by: Simin Wen, et al.
Published: (2021-07-01)

Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program
by: Javier Sánchez Ramírez, et al.
Published: (2020-03-01)

Immunotherapy and Vaccine Development
by: Carol Leung, et al.
Published: (2018-01-01)

In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies
by: vFatemeh Kazemi-Lomedasht v, et al.
Published: (2017-05-01)

Coronavirus new variants: the mutations cause and the effect on the treatment and vaccination
by: Rasha Raheem, et al.
Published: (2021-06-01)

Vascular Normalization and Cancer Immunotherapy
by: Junli ZENG, et al.
Published: (2014-03-01)

Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies
by: Oliver Butters, et al.
Published: (2019-07-01)

Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
by: Mary A. Wood, et al.
Published: (2020-03-01)

Allergy vaccines for specific immunotherapy
by: S. Yu. Petrova, et al.
Published: (2021-03-01)

Therapeutic Vaccines and Cancer Immunotherapy
by: Darshak Bhatt, et al.
Published: (2020-10-01)

Vaccine Immunotherapy for Celiac Disease
by: Antonio Di Sabatino, et al.
Published: (2018-06-01)

Synthetic Nanoparticles for Vaccines and Immunotherapy
by: Rakhra, Kavya, et al.
Published: (2017)

Influenza Virus Vaccines and Immunotherapies
Published: (2016)

Hydrogen peroxide signaling in vascular endothelial cells
by: Rosa Bretón-Romero, et al.
Published: (2014-01-01)

The Role of Soluble Fibrin in Lymphocyte and LAK Cell Adherence to and Migration across Vascular Endothelial Cells: Implications for Immunotherapy and Cancer
by: Weidow, Brandy Lee
Published: (2007)

A Mutation in <i>ZNF143</i> as a Novel Candidate Gene for Endothelial Corneal Dystrophy
by: Yonggoo Kim, et al.
Published: (2019-08-01)

Therapeutic cancer vaccines and combination immunotherapies involving vaccination
by: Nguyen T, et al.
Published: (2014-10-01)

The role of specific alternative splice variants of Vascular Endothelial growth factor/vascular permeability factor in Murine Multistage Skin Carcinogenesis /
by: Tober, Kathleen Lynn
Published: (2001)

Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma
by: A K Golenkov, et al.
Published: (2013-07-01)

Evidence for post-translational processing of vascular endothelial (VE)-cadherin in brain tumors: towards a candidate biomarker.
by: Isabelle Vilgrain, et al.
Published: (2013-01-01)

A naturally occurring hypoallergenic variant of vespid Antigen 5 from Polybia scutellaris venom as a candidate for allergen-specific immunotherapy.
by: Sabrina E Vinzón, et al.
Published: (2012-01-01)

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
by: Ji Yun Noh, et al.
Published: (2021-05-01)

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate
by: Yi‐Hao Chan, et al.
Published: (2019-06-01)

Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2
by: Li, C., et al.
Published: (2022)

mRNA vaccine for cancer immunotherapy
by: Lei Miao, et al.
Published: (2021-02-01)

The Development of Tumor Neoantigen Vaccine Immunotherapy
by: Wang Wanqiu
Published: (2019-01-01)

DC-Based Vaccines for Cancer Immunotherapy
by: Chunmei Fu, et al.
Published: (2020-11-01)

Melanoma immunotherapy: dendritic cell vaccines
by: Ivan Lozada-Requena, et al.
Published: (2015-09-01)

Neoantigen vaccine: an emerging tumor immunotherapy
by: Miao Peng, et al.
Published: (2019-08-01)

Editorial: Influenza Virus Vaccines and Immunotherapies
by: Arun eKumar, et al.
Published: (2015-11-01)

Dendritic cell vaccines in tumor immunotherapy
by: Wurzenberger, Cornelia
Published: (2009)